This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 2000-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000-2001
Title: Innovations of Hideki Kubota
Introduction
Hideki Kubota is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target central nervous system disorders. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
One of his latest patents is for a tricyclic pyrrole or pyrazole derivative. This compound is represented by a specific general formula and is noted for its strong affinity and selectivity for the 5-HT receptor. It is particularly useful in treating central nervous system diseases, including sexual disorders, eating disorders, anxiety, depression, and sleeping disorders. Another patent involves pyrido[2,3-D]pyrimidine derivatives and pharmaceutical compositions, showcasing his innovative approach to drug development.
Career Highlights
Hideki Kubota is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing research and development efforts. His work has contributed to the company's reputation for innovation in the pharmaceutical industry.
Collaborations
He has collaborated with notable coworkers, including Kazuhisa Takayama and Hiroyuki Hisamichi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Hideki Kubota's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health issues. His patents reflect a deep understanding of medicinal chemistry and a dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile